Literature DB >> 169012

Genetic control of the expression of murine leukemia virus proteins in tissues of normal, young adult mice.

M Strand, F Lilly, J T August.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169012     DOI: 10.1101/sqb.1974.039.01.127

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


× No keyword cloud information.
  7 in total

1.  Antibody response of mice to chemically induced tumors.

Authors:  J P Brown; J M Klitzman; I Hellström; R C Nowinski; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Genetic control of resistance to tumors.

Authors:  J M Phillips-Quagliata; M C Walker
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

3.  Isolation and comparison of murine leukemia virus-related glycoproteins from AKR and New Zealand mice.

Authors:  S J Kennel
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

4.  C-type virus protein p30 in blood from inbred mice correlates with their later incidence of leukemia.

Authors:  B A Nexø; H H Krog
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

5.  Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70.

Authors:  C L Reading; K W Brunson; M Torrianni; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Expression of murine leukemia virus envelope glycoprotein gp69/71 on mouse thymocytes. Evidence for two structural variants distinguished by presence vs. absence of GIX antigen.

Authors:  J S Tung; E Fleissner; E S Vitetta; E A Boyse
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

7.  Relationships of gp70 of MuLV envelopes to gp70 components of mouse lymphocyte plasma membranes.

Authors:  J S Tung; P V O'Donnell; E Fleissner; E A Boyse
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.